Yahoo Web Search

Search results

    • Q1 2024 Xeris Biopharma Holdings Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

      Moving to Gvoke. Gvoke's net sales increased approximately 10% in the quarter compared to prior year, while Gvoke prescriptions grew 27%. This net sales ...

    • Q1 2024 Supernus Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

      In addition, we plan to initiate a Phase one single dose study of SPM. four four three in healthy adults following submission of an investigational new drug

    • Q1 2024 Legend Biotech Corp Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      We're laser-focused on completing physical expansion of our Raritan site this year. We plan to double CARVYKTI capacity by the end of 2024 compared to the ...